Skip to main content
Clinical Trials/CTRI/2024/09/073692
CTRI/2024/09/073692
Recruiting
Phase 4

The analgesic effect and patient satisfaction following bupivacaine infiltration in the extra peritoneal space in patients undergoing laparocopic TAPP repair for unilateral inguinal hernias A Randomized controlled Trial

AIIMS Jodhpur Research Section1 site in 1 country202 target enrollmentStarted: September 21, 2024Last updated:

Overview

Phase
Phase 4
Status
Recruiting
Sponsor
AIIMS Jodhpur Research Section
Enrollment
202
Locations
1
Primary Endpoint
Analgesic effect of bupivacine infiltration into port wounds and extraperitoneal space compared to placebo (normal saline) after 6 ,12 , 24 hours of surgery

Overview

Brief Summary

The study will include all adult male inguinal hernia patients undergoing TAPP. Total 202 patients will be randomized for the study just before the procedure. The study patients will be introduced with infiltration of 0.5% bupivacaine and other patients will be introduced with normal saline in the extra-peritoneal space and port site. The study patients will be compared for postoperative outcomes likes pain at 6, 12 and 24 hours after surgery

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 80.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • All male patients between specified age undergoing unilateral TAPP will be included.

Exclusion Criteria

  • Recuurent hernia , Previous laparotomy ,substance abuse or opium addiction , psychiatric patients, uncontrolled comorbidities, history of drug allergy.

Outcomes

Primary Outcomes

Analgesic effect of bupivacine infiltration into port wounds and extraperitoneal space compared to placebo (normal saline) after 6 ,12 , 24 hours of surgery

Time Frame: VAS pain score after 6 ,12 , 24 hours of surgery

Secondary Outcomes

  • To compare patient satisfaction level(At time of discharge from the hospital ( 1 or 2 days after OT ))

Investigators

Sponsor
AIIMS Jodhpur Research Section
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Dr Satya Prakash Meena

AIIMS Jodhpur

Study Sites (1)

Loading locations...

Similar Trials